EUVIMEDEUVIMED entdecken
Open Access

CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer

Qing Gao iD, Kehong Wei, Deshen Pan, Chaoliang Xu iD, Yufei Xi, Yan Zhang iD, Arnaud Augert, David MacPherson iD, Deshui Jia iD

Science Advances · 2026

DOI: 10.1126/sciadv.aef1693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Qing Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Institute of Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai…. Hauptthemen laut MEDLINE: CREB-Binding Protein, Lung Neoplasms, Epigenesis, Genetic, Small Cell Lung Carcinoma. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Shanghai Pujiang Scholar Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most small cell lung cancers (SCLCs) exhibit low immunogenicity and intrinsic resistance to immunotherapy, yet the underlying mechanisms remain poorly understood. Here, we identify CREBBP loss, a frequent genetic alteration in SCLC, as a key suppressor of tumor cell-intrinsic immune responses that drives an immune-cold tumor microenvironment in Rb1/Trp53 -driven autochthonous mouse models. Consistently, Crebbp deletion promotes immune escape in syngeneic SCLC models. Mechanistically, Crebbp loss suppresses Sting and major histocompatibility complex class-I expression by reducing histone H3 acetylation. Notably, HDAC inhibition restores histone acetylation, reactivates these silenced genes, and induces tumor cell-intrinsic immune responses. Moreover, pharmacological HDAC inhibition synergizes with immune checkpoint blockade to suppress tumor growth in both Crebbp -mutant and Crebbp -wild-type SCLCs, with a more prominent effect in Crebbp -mutant tumors. Collectively, these findings establish CREBBP loss as a key mechanism of immune evasion and immunotherapy resistance in SCLC, highlighting HDAC inhibition as a promising strategy to enhance immunotherapy efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CREB-Binding ProteinLung NeoplasmsEpigenesis, GeneticSmall Cell Lung CarcinomaMembrane ProteinsTumor EscapeAnimalsMiceSTING ProteinHumansHistone Deacetylase InhibitorsGene Expression Regulation, NeoplasticHistonesAcetylationCell Line, TumorGene SilencingTumor MicroenvironmentImmunoediting, Cancer

Substanzen

CREB-Binding ProteinSTING ProteinMembrane ProteinsHistone Deacetylase InhibitorsHistonesSting1 protein, mouseCrebbp protein, mouse

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Institute of Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Pathology, Yale School of Medicine, Yale University, New Haven, CT, USA.
  • Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.
  • Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA.

ORCID-Profile: Qing Gao, Chaoliang Xu, Yan Zhang, David MacPherson, Deshui Jia

Förderung

  • National Natural Science Foundation of China
  • Shanghai Pujiang Scholar Program

Zitieren

APA

Gao, Q., Wei, K., Pan, D., Xu, C., Xi, Y., Zhang, Y., Augert, A., MacPherson, D., & Jia, D. (2026). CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer. Science Advances. https://doi.org/10.1126/sciadv.aef1693

Vancouver

Gao Q, Wei K, Pan D, Xu C, Xi Y, Zhang Y, et al. CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer. Science Advances. 2026. doi:10.1126/sciadv.aef1693

BibTeX
@article{Gao2026,
  author = {Gao, Qing and Wei, Kehong and Pan, Deshen and Xu, Chaoliang and Xi, Yufei and Zhang, Yan and Augert, Arnaud and MacPherson, David and Jia, Deshui},
  title = {CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aef1693}
}
Kostenlos starten →